Cargando…

Personalized warning signals for depressive relapse: A qualitative study

INTRODUCTION: An important aspect of depression relapse prevention programs is identifying personalized warning signals (PWS). These PWS are typically defined as depressive symptoms. Yet, no study has investigated to what extend PWS fit within the diagnostic classification framework, and how this co...

Descripción completa

Detalles Bibliográficos
Autores principales: Slofstra, C., Castelein, S., Pieper, A., Dijkstra, G., Hoenders, R., Booij, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471442/
http://dx.doi.org/10.1192/j.eurpsy.2021.889
_version_ 1784789076436582400
author Slofstra, C.
Castelein, S.
Pieper, A.
Dijkstra, G.
Hoenders, R.
Booij, S.
author_facet Slofstra, C.
Castelein, S.
Pieper, A.
Dijkstra, G.
Hoenders, R.
Booij, S.
author_sort Slofstra, C.
collection PubMed
description INTRODUCTION: An important aspect of depression relapse prevention programs is identifying personalized warning signals (PWS). These PWS are typically defined as depressive symptoms. Yet, no study has investigated to what extend PWS fit within the diagnostic classification framework, and how this compares to a more transdiagnostic, integrative approach towards depression. OBJECTIVES: To examine how well PWS reflect depressive symptoms, describe the remaining PWS, and examine how well PWS can be assigned to domains of an existing transdiagnostic and integrative framework, the positive health concept. METHODS: 162 PWS of 66 individuals with a history of depression were labeled as one or more symptoms of depression or to a residual category. The same process was repeated for labeling the domains of the positive health model. Labeling was done by three independent reviewers (inter-rater percent agreement: symptoms: 0.83 & positive health domains: 0.73). Disagreements were resolved by discussion. RESULTS: The three most commonly reported depressive symptoms were insomnia/hypersomnia, anhedonia and fatigue/loss of energy. However, sixty-five percent of the PWS were not depressive symptoms, but other symptoms (e.g. irritability, rumination) or aspects of functioning (e.g. withdrawing, managing time). The positive health domains captured all the PWS. However, 44% of PWS were labeled as multiple positive health domains, whereas labeling as symptoms of depression resulted in almost no such overlap. CONCLUSIONS: A more transdiagnostic and integrative approach seems necessary to capture PWS. Depending on one’s purpose, one may consider expanding the definition with other symptoms and aspects of functioning, or using the positive health concept.
format Online
Article
Text
id pubmed-9471442
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-94714422022-09-29 Personalized warning signals for depressive relapse: A qualitative study Slofstra, C. Castelein, S. Pieper, A. Dijkstra, G. Hoenders, R. Booij, S. Eur Psychiatry Abstract INTRODUCTION: An important aspect of depression relapse prevention programs is identifying personalized warning signals (PWS). These PWS are typically defined as depressive symptoms. Yet, no study has investigated to what extend PWS fit within the diagnostic classification framework, and how this compares to a more transdiagnostic, integrative approach towards depression. OBJECTIVES: To examine how well PWS reflect depressive symptoms, describe the remaining PWS, and examine how well PWS can be assigned to domains of an existing transdiagnostic and integrative framework, the positive health concept. METHODS: 162 PWS of 66 individuals with a history of depression were labeled as one or more symptoms of depression or to a residual category. The same process was repeated for labeling the domains of the positive health model. Labeling was done by three independent reviewers (inter-rater percent agreement: symptoms: 0.83 & positive health domains: 0.73). Disagreements were resolved by discussion. RESULTS: The three most commonly reported depressive symptoms were insomnia/hypersomnia, anhedonia and fatigue/loss of energy. However, sixty-five percent of the PWS were not depressive symptoms, but other symptoms (e.g. irritability, rumination) or aspects of functioning (e.g. withdrawing, managing time). The positive health domains captured all the PWS. However, 44% of PWS were labeled as multiple positive health domains, whereas labeling as symptoms of depression resulted in almost no such overlap. CONCLUSIONS: A more transdiagnostic and integrative approach seems necessary to capture PWS. Depending on one’s purpose, one may consider expanding the definition with other symptoms and aspects of functioning, or using the positive health concept. Cambridge University Press 2021-08-13 /pmc/articles/PMC9471442/ http://dx.doi.org/10.1192/j.eurpsy.2021.889 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Slofstra, C.
Castelein, S.
Pieper, A.
Dijkstra, G.
Hoenders, R.
Booij, S.
Personalized warning signals for depressive relapse: A qualitative study
title Personalized warning signals for depressive relapse: A qualitative study
title_full Personalized warning signals for depressive relapse: A qualitative study
title_fullStr Personalized warning signals for depressive relapse: A qualitative study
title_full_unstemmed Personalized warning signals for depressive relapse: A qualitative study
title_short Personalized warning signals for depressive relapse: A qualitative study
title_sort personalized warning signals for depressive relapse: a qualitative study
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471442/
http://dx.doi.org/10.1192/j.eurpsy.2021.889
work_keys_str_mv AT slofstrac personalizedwarningsignalsfordepressiverelapseaqualitativestudy
AT casteleins personalizedwarningsignalsfordepressiverelapseaqualitativestudy
AT piepera personalizedwarningsignalsfordepressiverelapseaqualitativestudy
AT dijkstrag personalizedwarningsignalsfordepressiverelapseaqualitativestudy
AT hoendersr personalizedwarningsignalsfordepressiverelapseaqualitativestudy
AT booijs personalizedwarningsignalsfordepressiverelapseaqualitativestudy